November 6, 2013 Comments Off on Cancer remains the dominant disease target for biotech through to 2010 Posted in: General Biotechnology This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Cancer remains the dominant disease target for biotech through to 2010
Go to paperABSTRACT: The two leading therapeutic areas for biological products, in t…
October 28, 2013 Comments Off on Fourth edition of Building Biotechnology coming soon Posted in: General Biotechnology The fourth edition of Building Biotechnology, the premier biotechnology industry primer, is slated for publication in December and is ready for reviewers. Building Biotechnology has been adopted by dozens of educational programs, and is on the nightstands of many biotech CEOs. The book covers a broad range of essential knowledge in business, regulations, patents, law, policy, and science. […]